IHS Chemical Week

World News and Views :: Top of the News

BASF to acquire US enzyme biotechnology company Verenium

4:45 AM MDT | September 20, 2013 | Deepti Ramesh

BASF says that its BASF Corp. subsidiary has entered into an agreement to begin a cash tender offer for all the outstanding shares of common stock of industrial biotechnology company Verenium (San Diego), for $4/share. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be about $62 million, BASF says. Verenium, which is focused on the development and commercialization of high-performance enzymes, recorded sales of $57 million in 2012. The offer corresponds to a premium of 56% above the volume-weighted average...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa